ISSN: 1746-0913
Journal Home
Journal Guideline
Future Microbiology Q3 Unclaimed
Future Microbiology is a journal indexed in SJR in Microbiology and Microbiology (medical) with an H index of 96. It has an SJR impact factor of 0,601 and it has a best quartile of Q3. It has an SJR impact factor of 0,601.
Future Microbiology focuses its scope in these topics and keywords: impact, drug, proteins, putative, staphylococcus, pathogenesis, mycobacterium, tuberculosisevolutionary, epoxide, acidophilusright, ...
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,601
SJR Impact factor96
H Index143
Total Docs (Last Year)441
Total Docs (3 years)6543
Total Refs1184
Total Cites (3 years)409
Citable Docs (3 years)2.76
Cites/Doc (2 years)45.76
Ref/DocOther journals with similar parameters
Protist Q3
International Microbiology Q3
Indian Journal of Microbiology Q3
Vector-Borne and Zoonotic Diseases Q3
Canadian Journal of Infectious Diseases and Medical Microbiology Q3
Compare this journals
Aims and Scope
Best articles by citations
Adherence to Surgical Care Improvement Project measures: the whole is greater than the parts
View moreCumulative irritation, sensitizing potential, phototoxicity and photoallergy of ozenoxacin in healthy adult volunteers
View moreImmune response toAspergillus fumigatusin compromised hosts: from bedside to bench
View moreEpstein-Barr virus and multiple sclerosis: causation or association?
View moreArtemisinin-resistantPlasmodium falciparum: can the genie be put back in the bottle?
View moreGiving a voice to those who die young: the fatal impact of tuberculosis and HIV in South Africa
View moreContaminated water delivery as a simple and effective method of experimental Salmonella infection
View moreDevelopment of humanized mouse models to study human malaria parasite infection
View more5'-UTR ofmalSincreases the invasive capacity ofSalmonella entericaserovar Typhi by influencing the expression ofbax
View moreInfluenza B viruses: not to be discounted
View moreEvaluation of phenotypic and molecular methods for identification ofStreptococcus pneumoniae
View moreEtiological diagnosis of pericardial effusion
View moreIn vitropercutaneous absorption and metabolism of ozenoxacin in excised human skin
View moreMALDI-TOF mass spectrometry-based direct-on-target microdroplet growth assay: a novel assay for susceptibility testing and beyond
View moreEmerging resistance in Gram-negative pathogens and implications for clinical practice
View moreViruses and human breast cancer
View moreHigh respiratory virus oropharyngeal carriage rate duringKingella kingaeosteoarticular infections in children
View moreInsights intoStreptococcus pyogenespathogenesis from transcriptome studies
View moreOzenoxacin: a review of absorption, dermal exposure and toxicity, tolerability and safety studies
View moreResidual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye
View moreSmall noncoding RNA: novel targets for antiviral therapy
View moreAntimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials
View moreResource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model?
View moreAnidulafungin: a novel echinocandin for candida infections
View more
Comments